{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:38:52Z","timestamp":1792471132157,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s40257-022-00753-5","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T07:44:21Z","timestamp":1676619861000},"page":"275-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management"],"prefix":"10.1007","volume":"24","author":[{"given":"Gil","family":"Yosipovitch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan T.","family":"Nedorost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2095-5096","authenticated-orcid":false,"given":"Juliana M.","family":"Canosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"issue":"4","key":"753_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s13670-018-0257-x","volume":"7","author":"AK Rzepecki","year":"2018","unstructured":"Rzepecki AK, Blasiak R. Stasis dermatitis: differentiation from other common causes of lower leg inflammation and management strategies. Curr Geriat Rep. 2018;7(4):222\u20137.","journal-title":"Curr Geriat Rep."},{"issue":"3","key":"753_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40257-016-0250-0","volume":"18","author":"S Sundaresan","year":"2017","unstructured":"Sundaresan S, Migden MR, Silapunt S. Stasis dermatitis: pathophysiology, evaluation, and management. Am J Clin Dermatol. 2017;18(3):383\u201390.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"753_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0733-8635(03)00113-X","volume":"22","author":"A Theodosat","year":"2004","unstructured":"Theodosat A. Skin diseases of the lower extremities in the elderly. Dermatol Clin. 2004;22(1):13\u201321.","journal-title":"Dermatol Clin"},{"issue":"5","key":"753_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJMra055289","volume":"355","author":"JJ Bergan","year":"2006","unstructured":"Bergan JJ, Schmid-Sch\u00f6nbein GW, Smith PDC, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med. 2006;355(5):488\u201398.","journal-title":"N Engl J Med."},{"issue":"4","key":"753_CR5","first-page":"130","volume":"40","author":"N Labropoulos","year":"2003","unstructured":"Labropoulos N. Hemodynamic changes according to the CEAP classification. Phlebolymphol. 2003;40(4):130\u20136.","journal-title":"Phlebolymphol."},{"issue":"3","key":"753_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.annepidem.2004.05.015","volume":"15","author":"JL Beebe-Dimmer","year":"2005","unstructured":"Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15(3):175\u201384.","journal-title":"Ann Epidemiol"},{"issue":"2","key":"753_CR7","first-page":"225","volume":"26","author":"KO Bawakid","year":"2005","unstructured":"Bawakid KO, Al-Raddadi RM, Sabban SS, Alturky KA, Mohamed MS. Prevalence of chronic venous insufficiency in the Saudi adult population. Saudi Med J. 2005;26(2):225\u20139.","journal-title":"Saudi Med J"},{"issue":"3","key":"753_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/jech.53.3.149","volume":"53","author":"C Evans","year":"1999","unstructured":"Evans C, Fowkes F, Ruckley C, Lee A. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Comm Heal. 1999;53(3):149\u201353.","journal-title":"J Epidemiol Comm Heal."},{"issue":"4","key":"753_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ejvs.2005.06.005","volume":"30","author":"R Chiesa","year":"2005","unstructured":"Chiesa R, Marone EM, Limoni C, Volont\u00e9 M, Schaefer E, Petrini O. Chronic venous insufficiency in Italy: the 24-cities cohort study. Eur J Vascul Endovascul Surg. 2005;30(4):422\u20139.","journal-title":"Eur J Vascul Endovascul Surg."},{"issue":"4","key":"753_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/153100350501700406","volume":"17","author":"JV White","year":"2005","unstructured":"White JV, Ryjewski C. Chronic venous insufficiency. Perspect Vascul Surg Endovascul Therap. 2005;17(4):319\u201327.","journal-title":"Perspect Vascul Surg Endovascul Therap."},{"issue":"5","key":"753_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.12968\/bjcn.2009.14.5.42076","volume":"14","author":"L Nazarko","year":"2009","unstructured":"Nazarko L. Diagnosis and treatment of venous eczema. Br J Community Nurs. 2009;14(5):188\u201394.","journal-title":"Br J Community Nurs"},{"issue":"2","key":"753_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/ije\/15.2.210","volume":"15","author":"FHDA Maffei","year":"1986","unstructured":"Maffei FHDA, Magaldi C, Pinho S, Lastoria S, Pinho W, Yoshida W, et al. Varicose veins and chronic venous insufficiency in Brazil: prevalence among 1755 inhabitants of a country town. Int J Epidemiol. 1986;15(2):210\u20137.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"753_CR13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1365-4632.2005.02607.x","volume":"45","author":"B Yal\u00e7in","year":"2006","unstructured":"Yal\u00e7in B, Tamer E, Toy GG, Ozta\u015f P, Hayran M, Alli N. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol. 2006;45(6):672\u20136.","journal-title":"Int J Dermatol"},{"issue":"2","key":"753_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/HNP.0000000000000072","volume":"29","author":"E Tracz","year":"2015","unstructured":"Tracz E, Zamojska E, Modrzejewski A, Zaborski D, Grzesiak W. Quality of life in patients with venous stasis ulcers and others with advanced venous insufficiency. Holis Nurs Pract. 2015;29(2):96\u2013102.","journal-title":"Holis Nurs Pract."},{"issue":"4","key":"753_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jvs.2006.05.051","volume":"44","author":"EA Nelson","year":"2006","unstructured":"Nelson EA, Harper DR, Prescott RJ, Gibson B, Brown D, Ruckley CV. Prevention of recurrence of venous ulceration: randomized controlled trial of class 2 and class 3 elastic compression. J Vasc Surg. 2006;44(4):803\u20138.","journal-title":"J Vasc Surg"},{"issue":"3","key":"753_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jvsv.2019.12.075","volume":"8","author":"F Lurie","year":"2020","unstructured":"Lurie F, Passman M, Meisner M, Dalsing M, Masuda E, Welch H, et al. The 2020 update of the CEAP classification system and reporting standards. J Vascul Surg Ven Lymph Disord. 2020;8(3):342\u201352.","journal-title":"J Vascul Surg Ven Lymph Disord."},{"issue":"4","key":"753_CR17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jid.2019.09.012","volume":"140","author":"T Hashimoto","year":"2020","unstructured":"Hashimoto T, Kursewicz CD, Fayne RA, Nanda S, Shah SM, Nattkemper L, et al. Mechanisms of itch in stasis dermatitis: significant role of IL-31 from macrophages. J Invest Dermatol. 2020;140(4):850\u20139.","journal-title":"J Invest Dermatol"},{"key":"753_CR18","first-page":"1708","volume":"2008","author":"AD Morris","year":"2008","unstructured":"Morris AD. Cellulitis and erysipelas. BMJ Clin Evid. 2008;2008:1708.","journal-title":"BMJ Clin Evid"},{"key":"753_CR19","unstructured":"Institute for Quality and Efficiency in Health Care (IQWiG). Erysipelas and cellulitis: Overview. 2015 Jun 03 [cited 2022 Nov 11]; https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK303996\/"},{"issue":"5","key":"753_CR20","first-page":"239","volume":"86","author":"B Palmer","year":"2010","unstructured":"Palmer B, Xia Y, Cho S, Lewis FS. Acroangiodermatitis secondary to chronic venous insufficiency. Cutis. 2010;86(5):239\u201340.","journal-title":"Cutis"},{"issue":"5","key":"753_CR21","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1067\/mva.2003.168","volume":"37","author":"RM Kaplan","year":"2003","unstructured":"Kaplan RM, Criqui MH, Denenberg JO, Bergan J, Fronek A. Quality of life in patients with chronic venous disease: San Diego population study. J Vasc Surg. 2003;37(5):1047\u201353.","journal-title":"J Vasc Surg"},{"key":"753_CR22","doi-asserted-by":"crossref","unstructured":"Kahn SR, M'lan CE, Lamping DL, Kurz X, B\u00e9rard A, Abenhaim LA, et al. Relationship between clinical classification of chronic venous disease and patient-reported quality of life: results from an international cohort study. J Vasc Surg. 2004;39(4):823\u20138.","DOI":"10.1016\/j.jvs.2003.12.007"},{"key":"753_CR23","doi-asserted-by":"crossref","unstructured":"Valdes-Rodriguez R, Mollanazar NK, Gonz\u00e1lez-Muro J, Nattkemper L, Torres-Alvarez B, L\u00f3pez-Esqueda FJ, et al. Itch prevalence and characteristics in a Hispanic geriatric population: a comprehensive study using a standardized itch questionnaire. Acta Derm Venereol. 2015;95(4).","DOI":"10.2340\/00015555-1968"},{"issue":"1","key":"753_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/WON.0b013e318202c47a","volume":"38","author":"JC Paul","year":"2011","unstructured":"Paul JC, Pieper B, Templin TN. Itch: association with chronic venous disease, pain, and quality of life. J Wound Ostomy Continence Nurs. 2011;38(1):46\u201354.","journal-title":"J Wound Ostomy Continence Nurs"},{"issue":"2","key":"753_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0002-9610(01)00856-X","volume":"183","author":"M McGuckin","year":"2002","unstructured":"McGuckin M, Waterman R, Brooks J, Cherry G, Porten L, Hurley S, et al. Validation of venous leg ulcer guidelines in the United States and United Kingdom. Am J Surg. 2002;183(2):132\u20137.","journal-title":"Am J Surg"},{"issue":"1","key":"753_CR26","first-page":"59","volume":"12","author":"M Spiridon","year":"2017","unstructured":"Spiridon M, Corduneanu D. Chronic venous insufficiency: a frequently underdiagnosed and undertreated pathology. Maedica (Bucur). 2017;12(1):59\u201361.","journal-title":"Maedica (Bucur)."},{"issue":"3","key":"753_CR27","first-page":"134","volume":"11","author":"CT Sung","year":"2019","unstructured":"Sung CT, Taguines PR, Jacob SE. Stasis dermatitis. J Dermatol Nur Assoc. 2019;11(3):134\u20136.","journal-title":"J Dermatol Nur Assoc."},{"issue":"6","key":"753_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00439-010-0812-9","volume":"127","author":"A Fiebig","year":"2010","unstructured":"Fiebig A, Krusche P, Wolf A, Krawczak M, Timm B, Nikolaus S, et al. Heritability of chronic venous disease. Hum Gen. 2010;127(6):669\u201374.","journal-title":"Hum Gen"},{"issue":"7","key":"753_CR29","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1253\/circj.CJ-13-1599","volume":"78","author":"K Suehiro","year":"2014","unstructured":"Suehiro K, Morikage N, Murakami M, Yamashita O, Ueda K, Samura M, et al. A study of leg edema in immobile patients. Circ J. 2014;78(7):1733\u20139.","journal-title":"Circ J"},{"issue":"11","key":"753_CR30","first-page":"E149","volume":"26","author":"JA Zygmunt","year":"2014","unstructured":"Zygmunt JA. Duplex ultrasound for chronic venous insufficiency. J Invasive Cardiol. 2014;26(11):E149\u201355.","journal-title":"J Invasive Cardiol"},{"issue":"8","key":"753_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3949\/ccjm.79a.11121","volume":"79","author":"EC Keller","year":"2012","unstructured":"Keller EC, Tomecki KJ, Alraies MC. Distinguishing cellulitis from its mimics. Cleve Clin J Med. 2012;79(8):547\u201352.","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"753_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jaad.2014.11.012","volume":"73","author":"L Strazzula","year":"2015","unstructured":"Strazzula L, Cotliar J, Fox LP, Hughey L, Shinkai K, Gee SN, et al. Inpatient dermatology consultation aids diagnosis of cellulitis among hospitalized patients: a multi-institutional analysis. J Amer Acad Dermatol. 2015;73(1):70\u20135.","journal-title":"J Amer Acad Dermatol."},{"issue":"4","key":"753_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/1534734602239654","volume":"1","author":"R Renner","year":"2002","unstructured":"Renner R, Wollina U. Contact sensitization in patients with leg ulcers and\/or leg eczema: comparison between centers. Int J Low Extrem Wounds. 2002;1(4):251\u20135.","journal-title":"Int J Low Extrem Wounds"},{"key":"753_CR34","unstructured":"Id reaction (autoeczematization): background, pathophysiology, epidemiology 2018 Mar 23 [cited 2022 Jan 26]; https:\/\/emedicine.medscape.com\/article\/1049760-overview#a6"},{"issue":"7","key":"753_CR35","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-4632.2004.02213.x","volume":"43","author":"K Sardana","year":"2004","unstructured":"Sardana K, Sarkar R, Sehgal VN. Pigmented purpuric dermatoses: an overview. Int J Dermatol. 2004;43(7):482\u20138.","journal-title":"Int J Dermatol"},{"key":"753_CR36","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.2147\/DMSO.S286887","volume":"13","author":"PP Naik","year":"2020","unstructured":"Naik PP, Farrukh SN. Clinical significance of diabetic dermatopathy. Diabetes Metab Syndr Obes. 2020;13:4823\u20137.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"Suppl 1","key":"753_CR37","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.1007\/s12325-019-0881-7","volume":"36","author":"AH Davies","year":"2019","unstructured":"Davies AH. The seriousness of chronic venous disease: a review of real-world evidence. Adv Ther. 2019;36(Suppl 1):5S-12S.","journal-title":"Adv Ther"},{"issue":"Suppl 5","key":"753_CR38","doi-asserted-by":"publisher","first-page":"2S","DOI":"10.1016\/j.jvs.2011.01.079","volume":"53","author":"P Gloviczki","year":"2011","unstructured":"Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(Suppl 5):2S-48S.","journal-title":"J Vasc Surg"},{"issue":"2","key":"753_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S1078-5884(96)80051-7","volume":"11","author":"SP Payne","year":"1996","unstructured":"Payne SP, London NJ, Newland CJ, Thrush AJ, Barrie WW, Bell PR. Ambulatory venous pressure: correlation with skin condition and role in identifying surgically correctible disease. Eur J Vasc Endovasc Surg. 1996;11(2):195\u2013200.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"8","key":"753_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1258\/phleb.2010.010043","volume":"26","author":"K Sippel","year":"2011","unstructured":"Sippel K, Mayer D, Ballmer B, Dragieva G, L\u00e4uchli S, French L, et al. Evidence that venous hypertension causes stasis dermatitis. Phlebology. 2011;26(8):361\u20135.","journal-title":"Phlebology"},{"issue":"6638","key":"753_CR41","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/bmj.296.6638.1693","volume":"296","author":"PR Thomas","year":"1988","unstructured":"Thomas PR, Nash GB, Dormandy JA. White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. Br Med J (Clin Res Ed). 1988;296(6638):1693\u20135.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"4","key":"753_CR42","first-page":"311","volume":"5","author":"C Moyses","year":"1987","unstructured":"Moyses C, Cederholm-Williams SA, Michel CC. Haemoconcentration and accumulation of white cells in the feet during venous stasis. Int J Microcirc Clin Exp. 1987;5(4):311\u201320.","journal-title":"Int J Microcirc Clin Exp"},{"issue":"4","key":"753_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/0741-5214(93)90109-Y","volume":"17","author":"L Wilkinson","year":"1993","unstructured":"Wilkinson L, Bunker C, Edwards J, Scurr J, Smith PC. Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg. 1993;17(4):669\u201375.","journal-title":"J Vasc Surg"},{"issue":"5","key":"753_CR44","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ejvs.2004.05.012","volume":"28","author":"S Takase","year":"2004","unstructured":"Takase S, Pascarella L, Lerond L, Bergan JJ, Schmid-Sch\u00f6nbein GW. Venous hypertension, inflammation and valve remodeling. Eur J Vasc Endovasc Surg. 2004;28(5):484\u201393.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"753_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/000155599750011651","volume":"79","author":"M Peschen","year":"1999","unstructured":"Peschen M, Lahaye T, Hennig B, Weyl A, Simon JC, Vanscheidt W. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency. Acta Dermat Venereol. 1999;79(1):27\u201332.","journal-title":"Acta Dermat Venereol."},{"issue":"3","key":"753_CR46","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0923-1811(00)00128-6","volume":"25","author":"Y Herouy","year":"2001","unstructured":"Herouy Y, Mellios P, Bandemir E, Dichmann S, Nockowski P, Sch\u00f6pf E, et al. Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression. J Dermatol Sci. 2001;25(3):198\u2013205.","journal-title":"J Dermatol Sci"},{"issue":"6","key":"753_CR47","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1046\/j.1523-1747.2001.01345.x","volume":"116","author":"J Wenk","year":"2001","unstructured":"Wenk J, Foitzik A, Achterberg V, Sabiwalsky A, Dissemond J, Meewes C, et al. Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. J Invest Dermatol. 2001;116(6):833\u20139.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"753_CR48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1258\/phleb.2011.011038","volume":"27","author":"G Mosti","year":"2012","unstructured":"Mosti G, Picerni P, Partsch H. Compression stockings with moderate pressure are able to reduce chronic leg oedema. Phlebology. 2012;27(6):289\u201396.","journal-title":"Phlebology"},{"key":"753_CR49","first-page":"CD0000265","volume":"2","author":"N Cullum","year":"2001","unstructured":"Cullum N, Nelson E, Fletcher A, Sheldon T. Compression for venous leg ulcers. Cochr Data Syst Rev. 2001;2:CD0000265.","journal-title":"Cochr Data Syst Rev."},{"issue":"2","key":"753_CR50","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ejvs.2014.11.005","volume":"49","author":"K Sippel","year":"2015","unstructured":"Sippel K, Seifert B, Hafner J. Donning devices (foot slips and frames) enable elderly people with severe chronic venous insufficiency to put on compression stockings. Eur J Vasc Endovasc Surg. 2015;49(2):221\u20139.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"753_CR51","doi-asserted-by":"crossref","unstructured":"Stolk R, Wegen Van Der\u2010Franken C, Neumann H. A method for measuring the dynamic behavior of medical compression hosiery during walking. Dermatol Surg. 2004;30(5):729\u201336.","DOI":"10.1111\/j.1524-4725.2004.30203.x"},{"issue":"6","key":"753_CR52","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.avsg.2007.07.014","volume":"21","author":"S Raju","year":"2007","unstructured":"Raju S, Hollis K, Neglen P. Use of compression stockings in chronic venous disease: patient compliance and efficacy. Annals Vasc Surg. 2007;21(6):790\u20135.","journal-title":"Annals Vasc Surg."},{"issue":"10","key":"753_CR53","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1177\/0268355515608992","volume":"31","author":"K Suehiro","year":"2016","unstructured":"Suehiro K, Morikage N, Yamashita O, Harada T, Ueda K, Samura M, et al. Adherence to and efficacy of different compression methods for treating chronic venous insufficiency in the elderly. Phlebolog. 2016;31(10):723\u20138.","journal-title":"Phlebolog"},{"issue":"1","key":"753_CR54","first-page":"104","volume":"60","author":"J Mizuno","year":"2011","unstructured":"Mizuno J, In-Nami H. Allergic contact dermatitis to synthetic rubber, neoprene in compression stockings. Masui Jpn J Anesthesiol. 2011;60(1):104\u20136.","journal-title":"Masui Jpn J Anesthesiol."},{"key":"753_CR55","doi-asserted-by":"crossref","unstructured":"Kucharzewski M, K\u00f3zka M, Urbanek T. Topical treatment of nonhealing venous leg ulcer with propolis ointment. Evid-Bas Complem Alt Med. 2013;2013.","DOI":"10.1155\/2013\/254017"},{"key":"753_CR56","doi-asserted-by":"crossref","unstructured":"Kirkup ME. Xerosis and stasis dermatitis. Preventive Dermatology. London: Springer; 2011. p. 71\u201379.","DOI":"10.1007\/978-1-84996-021-2_8"},{"issue":"3","key":"753_CR57","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","volume":"75","author":"AS Paller","year":"2016","unstructured":"Paller AS, Tom WL, Lebwohl MG, Blumenthal RL, Boguniewicz M, Call RS, et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016;75(3):494\u2013503.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"753_CR58","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1024\/0301-1526.33.4.260","volume":"33","author":"J Dissemond","year":"2004","unstructured":"Dissemond J, Knab J, Lehnen M, Franckson T, Goos M. Successful treatment of stasis dermatitis with topical tacrolimus. Vasa. 2004;33(4):260\u20132.","journal-title":"Vasa"},{"key":"753_CR59","doi-asserted-by":"crossref","unstructured":"Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116\u201332.","DOI":"10.1016\/j.jaad.2014.03.023"},{"issue":"7","key":"753_CR60","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1046\/j.1524-4725.2000.99268.x","volume":"26","author":"A Tafazzoli","year":"2000","unstructured":"Tafazzoli A, Rostan EF, Goldman MP. Q-switched ruby laser treatment for postsclerotherapy hyperpigmentation. Dermatol Surg. 2000;26(7):653\u20136.","journal-title":"Dermatol Surg"},{"issue":"7","key":"753_CR61","first-page":"190","volume":"24","author":"H Parsa","year":"2012","unstructured":"Parsa H, Zangivand AA, Hajimaghsoudi L. The effect of pentoxifylline on chronic venous ulcers. Wounds. 2012;24(7):190\u20134.","journal-title":"Wounds"},{"issue":"8","key":"753_CR62","first-page":"989","volume":"81","author":"L Collins","year":"2010","unstructured":"Collins L, Seraj S. Diagnosis and treatment of venous ulcers. Am Fam Physician. 2010;81(8):989\u201396.","journal-title":"Am Fam Physician"},{"key":"753_CR63","first-page":"CD003230","volume":"11","author":"MH Pittler","year":"2012","unstructured":"Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochr Data System Rev. 2012;11:CD003230.","journal-title":"Cochr Data System Rev."},{"issue":"4","key":"753_CR64","first-page":"310","volume":"31","author":"F Allaert","year":"2012","unstructured":"Allaert F. Meta-analysis of the impact of the principal venoactive drugs agents on malleolar venous edema. Int Angiol. 2012;31(4):310\u20135.","journal-title":"Int Angiol"},{"issue":"2","key":"753_CR65","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/jcpt.12247","volume":"40","author":"Z Aziz","year":"2015","unstructured":"Aziz Z, Tang W, Chong N, Tho L. A systematic review of the efficacy and tolerability of hydroxyethylrutosides for improvement of the signs and symptoms of chronic venous insufficiency. J Clin Pharm Therap. 2015;40(2):177\u201385.","journal-title":"J Clin Pharm Therap."},{"issue":"4","key":"753_CR66","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1524-6175.2003.02402.x","volume":"5","author":"DA Sica","year":"2003","unstructured":"Sica DA. Calcium channel blocker-related peripheral edema: can it be resolved? J Clin Hyperten. 2003;5(4):291\u20135.","journal-title":"J Clin Hyperten"},{"issue":"2","key":"753_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/8755122518809005","volume":"35","author":"S Khadka","year":"2019","unstructured":"Khadka S, Joshi R, Shrestha DB, Shah D, Bhandari N, Maharjan M, et al. Amlodipine-induced pedal edema and its relation to other variables in patients at a tertiary level hospital of Kathmandu, Nepal. J Pharm Tech. 2019;35(2):51\u20135.","journal-title":"J Pharm Tech"},{"issue":"24","key":"753_CR68","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1001\/jama.2012.111352","volume":"308","author":"A Hamdan","year":"2012","unstructured":"Hamdan A. Management of varicose veins and venous insufficiency. JAMA. 2012;308(24):2612\u201321.","journal-title":"JAMA"},{"issue":"4","key":"753_CR69","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1258\/phleb.2009.008080","volume":"24","author":"P Chapman-Smith","year":"2009","unstructured":"Chapman-Smith P, Browne A. Prospective five-year study of ultrasound-guided foam sclerotherapy in the treatment of great saphenous vein reflux. Phlebolog. 2009;24(4):183\u20138.","journal-title":"Phlebolog"},{"issue":"4","key":"753_CR70","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/1531003508325054","volume":"20","author":"JI Almeida","year":"2008","unstructured":"Almeida JI, Raines JK. Ambulatory phlebectomy in the office. Perspect Vasc Surg Endovasc Therap. 2008;20(4):348\u201355.","journal-title":"Perspect Vasc Surg Endovasc Therap."},{"issue":"3","key":"753_CR71","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3390\/ijms23031209","volume":"23","author":"MA Schick","year":"2022","unstructured":"Schick MA, Schlegel N. Clinical implication of phosphodiesterase-4-inhibition. Int J Mol Sci. 2022;23(3):1209.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"753_CR72","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40257-020-00510-6","volume":"21","author":"J Schlessinger","year":"2020","unstructured":"Schlessinger J, Shepard JS, Gower R, Su JC, Lynde C, Cha A, et al. Safety, effectiveness, and pharmacokinetics of crisaborole in infants aged 3 to < 24 months with mild-to-moderate atopic dermatitis: a phase IV open-label study (CrisADe CARE 1). Am J Clin Dermatol. 2020;21(2):275\u201384.","journal-title":"Am J Clin Dermatol"},{"key":"753_CR73","unstructured":"ClinicalTrials.gov. Identifier NCT04091087 Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis. 2019 Sept 16 [cited 2022 Feb 01]; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04091087"},{"issue":"5","key":"753_CR74","first-page":"298","volume":"100","author":"SB Millan","year":"2019","unstructured":"Millan SB, Gan R, Townsend PE. Venous ulcers: diagnosis and treatment. Am Fam Physic. 2019;100(5):298\u2013305.","journal-title":"Am Fam Physic"},{"issue":"2","key":"753_CR75","first-page":"1","volume":"19","author":"Health Quality Ontario","year":"2019","unstructured":"Health Quality Ontario. Compression stockings for the prevention of venous leg ulcer recurrence: a health technology assessment. Ontario Health Technol Assess Ser. 2019;19(2):1\u201386.","journal-title":"Ontario Health Technol Assess Ser."},{"issue":"4","key":"753_CR76","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/bja\/aex269","volume":"119","author":"A Imbernon-Moya","year":"2017","unstructured":"Imbernon-Moya A, Ortiz-de Frutos F, Sanjuan-Alvarez M, Portero-Sanchez I, Merinero-Palomares R, Alcazar V. Treatment of chronic venous ulcers with topical sevoflurane: a retrospective clinical study. Br J Anaesth. 2017;119(4):846\u20137.","journal-title":"Br J Anaesth"},{"issue":"1","key":"753_CR77","first-page":"CD003557","volume":"10","author":"S O'Meara","year":"2014","unstructured":"O\u2019Meara S, Al-Kurdi D, Ologun Y, Ovington LG, Martyn-St James M, Richardson R. Antibiotics and antiseptics for venous leg ulcers. Cochr Data System Rev. 2014;10(1):CD003557.","journal-title":"Cochr Data System Rev."},{"issue":"3","key":"753_CR78","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1067\/mva.2003.131","volume":"37","author":"RL Tawes","year":"2003","unstructured":"Tawes RL, Barron ML, Coello AA, Joyce DH, Kolvenbach R. Optimal therapy for advanced chronic venous insufficiency. J Vasc Surg. 2003;37(3):545\u201351.","journal-title":"J Vasc Surg"},{"key":"753_CR79","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/bmj.39216.542442.BE","volume":"335","author":"MS Gohel","year":"2007","unstructured":"Gohel MS, Barwell JR, Taylor M, Chant T, Foy C, Earnshaw JJ, et al. Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial. BMJ. 2007;335:83.","journal-title":"BMJ"},{"issue":"3","key":"753_CR80","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4103\/2229-5178.137830","volume":"5","author":"R Rai","year":"2014","unstructured":"Rai R. Standard guidelines for management of venous leg ulcer. Ind Dermatol Onlin J. 2014;5(3):408\u201311.","journal-title":"Ind Dermatol Onlin J."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00753-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-022-00753-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00753-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T01:18:58Z","timestamp":1677287938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-022-00753-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1007\/s40257-022-00753-5","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,17]]},"assertion":[{"value":"20 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GY has been a consultant and an advisor for Pfizer Inc., Bellus, Eli Lilly and Company, Galderma, Kiniksa, LEO Pharma Novartis, Sanofi-Regeneron, and Trevi Therapeutics and is a principal investigator for Pfizer Inc., Kiniksa, LEO Pharma, Galderma, and Sanofi-Regeneron. JS served as an investigator for Celgene, Eli Lilly and Company, F. Hoffmann-LaRoche, Menlo Therapeutics, Realm Therapeutics, Regeneron, and Sanofi; as a consultant for Pfizer Inc., AbbVie, Anacor, AnaptysBio, Arena Pharmaceuticals, Dermavant, Dermira, Eli Lilly and Company, Galderma, GlaxoSmithKline, Glenmark, Incyte, Kiniksa Pharmaceuticals, LEO Pharma, Menlo Therapeutics, Novartis, Realm Therapeutics, Regeneron, and Sanofi; and as a speaker for Regeneron and Sanofi. JMC and AC are employees and stockholders of Pfizer Inc. AF has been a consultant and advisor for Pfizer Inc., AbbVie, Aveeno, Dermavant, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly and Company, Graegis, Galderma, Janssen, L'Or\u00e9al, Microcures, Mino Labs, Novartis, Sanofi-Regeneron, and Zylo Therapeutics and is a speaker for AbbVie, Bristol Myers Squibb, Dermavant, Janssen, and Sanofi-Regeneron. SN has received a Pfizer Learning and Change grant and has been an advisor for Pfizer Inc. and is Dermatology editor for the <i>New England Journal of Medicine<\/i> Healer educational resource.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Data sharing is not applicable to this article because no datasets were generated or analyzed during the current study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"The preparation of this review was supported by Pfizer Inc.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}